While the use of PrEP has helped drop the rates of HIV infections, instances of syphilis and chlamydia among queer men have ...

Doxycycline postexposure prophylaxis initiation is associated with decreases in sexually transmitted infections.

Both studies in JAMA Internal Medicine supported the rising profile of doxyPEP as a way to counter the epidemic of syphilis, ...

A study says that taking DoxyPEP reduced the incidence of chlamydia and syphilis by around 80%. DoxyPEP is short for ...

Quarterly syphilis rates decreased from 1.7% prior to doxyPEP availability to 0.3% afterward, while quarterly chlamydia rates ...

A new study has found that rates of chlamydia and syphilis plummet among people prescribed doxycycline for sexually ...

A new study in JAMA Internal Medicine led by the Harvard Pilgrim Health Care Institute examined whether doxycycline post-exposure prophylaxis (doxyPEP) was associated with declines in bacterial ...

Researchers have found in a new new study that Doxycycline post-exposure prophylaxis was effective strategy for reducing ...

It tends to be less effective at preventing gonorrhoea. DoxyPEP can be taken by those living with HIV and people who are HIV-negative. This approach may not be effective for cisgender women or people ...

PrEP and doxyPEP have significantly contributed to reducing HIV and STI transmission, highlighting the importance of prevention strategies. With new CDC data expressing optimism about the epidemic ...